At Tiger Aesthetics, we are committed to delivering new, cutting-edge products that meet the evolving needs of aesthetic practitioners and their patients.

With a focus on three primary clinical areas – reconstruction, cosmetic and regenerative – Tiger Aesthetics enables practitioners to provide life-changing results for a wide range of patients. These innovative technologies and products represent a unique opportunity for innovation to advance the field of Aesthetic Medicine.

In 2024, Tiger Aesthetics completed the acquisition of the Sientra® product portfolio, including HSC/HSC+ gel breast implants, AlloX2® and Dermaspan tissue expanders and the Viality fat transfer system. This strategic acquisition complements Tiger Aesthetics’ adipose cell and tissue products, alloClae and dermaClae, to provide new treatment options for plastic surgeons and patients.